Anti-inflammatory activity of polyphosphazene-based naproxen slow-release systems

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 5, 1996, Pages 468-473

  Conforti, Anita ^a,d   Bertani, Simone ^a   Lussignoli, Sabrina ^a   Grigolini, Luigi ^a   Terzi, Marta ^a   Lora, Silvano ^b   Caliceti, Paolo ^c   Marsilio, Franco ^c   Veronese, Francesco M ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d POLICLINICO BORGO ROMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; CHLORINE; ESTER; IMIDAZOLE; NAPROXEN; PHENYLALANINE; POLYMER; POLYPHOSPHAZINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG IMPLANT; DRUG RELEASE; EDEMA; INFLAMMATORY DISEASE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SUSTAINED RELEASE PREPARATION;

EID: 0029892505     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05956.x     Document Type: Article

References (15)

1. Ackerman, N. R., Rooks, W. H., Shott, L., Genant, H., Maloney, P, West, E. (1979) Effects of naproxen on connective tissue changes in the adjuvant arthritic rat. Arthritis Rheum. 22: 1365-1374
2. Allcock, H. R. (1990) Polyphosphazenes as new biomedical and bioactive materials. In: Chasin, M., Langer, R. (eds) Biodegradable Polymers as Drag Delivery Systems. Marcel Dekker, New York, pp 163-193
3. Brogden, R. K, Finder, R. M., Sawyer, P. R., Speight, T. M., Avery, G. S. (1975) Naproxen: a review of its pharmacological properties and therapeutic efficacy and use. Drugs 9: 326-363
4. Caliceti, P., Veronese, F. M., Marsilio, F., Lora, S., Seraglia, R., Traldi, P. (1992) Fast atom bombardment in the structural identification of intermediates in the hydrolytic degradation of polyphosphazenes. Org. Mass Spectrom. 27: 1199-1202
5. Caliceti, P., Lora, S., Marsilio, F., Guiotto, A., Veronese, F. M. (1994) Amino acid esters and imidazole derivatives of polyphosphazenes: influence on release of drugs, degradability and swelling. II Farmaco 49: 69-74
6. Cuzzolin, L., Conforti, A., Adami, A., Lussignoli, S., Menestrina, F., Del Soldato, P., Benoni, G. (1995) Anti-inflammatory potency and gastrointestinal toxicity of a new compound, nitronaproxen. Pharmacol. Res. 31: 61-65
7. Grollerman, C. W. J., De Visser, A. C., Wolke, J. G. C, Klein, C. P. A. T., Van Der Goot, H., Timmerman, H. (1986) Studies on a bioerodible drug carrier system based on a polyphosphazene. J. Contr. Rel. 4: 133-142
8. Kelly, J. G., Kinney, C. D., Devane, J. G., Mulligan, S., Colgan, B. V (1989) Pharmacokinetic properties and clinical efficacy of once-daily sustained-release naproxen. Eur. J. Clin. Pharmacol. 36: 383-388
9. Langone, F., Lora, S., Veronese, F. M,. Caliceti, P., Parnigotto, P. P., Valenti, F., Palma, G. (1995) Peripheral nerve repair using poly(organo)phosphazene tubular prothesis. Biomaterials 16: 347-353
10. Lauroba, J., Domenech, J., Moreno, J., Pla-Delfina, J. M. (1986) Relationship between biophasic disposition and pharmacokinetic behavior in nonsteroidal antiinflammatory drugs. Arzneim. Forsch. 36: 710- 714
11. Otterness, I. G., Bliven, M. L. (1985) Laboratory models for testing nonsteroidal antiinflammatory drugs. In: Lombardino, J. C. (eds) Nonsteroidal Antiinflammatory Drugs. John Wiley and Sons, New York, pp 111-249
12. Pilla, G., Capucci, M., Palazzini, E., Galli, G. (1990) Controlled-release naproxen: an assessment of efficacy and tolerance in arthropathic patients. Curr. Ther. Res. 48: 949-958
13. Runkel, R., Chaplin, M., Boost, G., Segre, E., Forcelli, E. (1972) Absorption, distribution, metabolism and excretion of naproxen in various laboratory animals and in human subjects. J. Pharm. Sci. 61: 703-708
14. Runkel, R. A., Forchielli, E., Selevius, H., Chaplin, M., Segre E. (1974) Non linear plasma level response to high doses of naproxen. Clin. Pharmacol. Ther. 15: 261-266
15. Sofia, R. D., Knobloch, L. C., Vassar, H. B. (1975) Inhibition of the primary lesion of adjuvant-induced polyarthritis in rats (18-hour arthritis test) for specific detection of clinically effective anti-arthritic drugs. J. Pharmacol. Exp. Ther. 193: 918-931